Midazolam microdose to determine systemic and pre-systemic metabolic CYP3A activity in humans-Reference-Cited by-同舟云学术

Midazolam microdose to determine systemic and pre-systemic metabolic CYP3A activity in humans

Published:2015-01-20 Issue:2 Volume:79 Page:278-285
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Hohmann Nicolas¹,Kocheise Franziska¹,Carls Alexandra¹,Burhenne Jürgen¹,Haefeli Walter E.¹,Mikus Gerd¹

Affiliation:

1. Department of Clinical Pharmacology and Pharmacoepidemiology; University of Heidelberg; Heidelberg Germany

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12502/fullpdf

Reference26 articles.

1. Pharmacogenomics: translating functional genomics into rational therapeutics;Evans;Science,1999

2. The human intestinal cytochrome P450 ‘pie’;Paine;Drug Metab Dispos,2006

3. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition;Dresser;Clin Pharmacokinet,2000

4. CDER Guidance for industry drug interaction studies - study design, data analysis, implications for dosing, and labeling recommendations 2012 http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm292362.pdf

5. EMA Guideline on the investigation of drug interactions 2012 http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/07/WC500129606.pdf

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enzyme-mediated drug-drug interactions: a review of in vivo and in vitro methodologies, regulatory guidance, and translation to the clinic;Drug Metabolism Reviews;2024-07-26

2. Value of Assessing 1‐Hydroxymidazolam in Drug‐Drug Interaction Studies with Midazolam as a Substrate of Cytochrome P450 3A;The Journal of Clinical Pharmacology;2024-05-26

3. Distribution and elimination kinetics of midazolam and metabolites after post-resuscitation care: a prospective observational study;Scientific Reports;2024-02-25

4. Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of Model-Informed Dosing in Clinical Care;Clinical Pharmacokinetics;2024-02-15

5. Plasma 6β‐hydroxycortisol to cortisol ratio as a less invasive cytochrome P450 3A phenotyping method;British Journal of Clinical Pharmacology;2024-01-07